Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing the prognostic capacity of baseline 18F-FDG PET/CT metabolic parameters in extranodal natural killer/T-cell lymphoma by using relative and absolute thresholds.
Zhu YM, Peng P, Liu X, Qi SN, Wang SL, Fang H, Song YW, Liu YP, Jin J, Li N, Lu NN, Jing H, Tang Y, Chen B, Zhang WW, Zhai YR, Yang Y, Liang B, Zheng R, Li YX. Zhu YM, et al. Among authors: zhai yr. Heliyon. 2024 Jan 23;10(3):e25184. doi: 10.1016/j.heliyon.2024.e25184. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322946 Free PMC article.
Prediction of 5-year overall survival of diffuse large B-cell lymphoma on the pola-R-CHP regimen based on 2-year event-free survival and progression-free survival.
Zhang WR, Liu X, Zhong QZ, Wu T, Yang Y, Chen B, Jing H, Tang Y, Jin J, Liu YP, Song YW, Fang H, Lu NN, Li N, Zhai YR, Zhang WW, Wang SL, Chen F, Yin L, Qi SN, Li YX. Zhang WR, et al. Among authors: zhai yr. Cancer Med. 2024 Jan 5;13(1):e6899. doi: 10.1002/cam4.6899. Online ahead of print. Cancer Med. 2024. PMID: 38180169 Free PMC article.
Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.
Wang X, Liu X, Zhong QZ, Wu T, Wu YP, Yang Y, Chen B, Jing H, Tang Y, Jin J, Liu YP, Song YW, Fang H, Lu NN, Li N, Zhai YR, Zhang WW, Wang SL, Chen F, Qi SN, Li YX. Wang X, et al. Among authors: zhai yr. Radiother Oncol. 2023 Nov;188:109902. doi: 10.1016/j.radonc.2023.109902. Epub 2023 Sep 9. Radiother Oncol. 2023. PMID: 37678622
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation Therapy.
Wang DQ, Zhang N, Dong LH, Zhong YH, Wu HF, Zhong QZ, Jin J, Hou XR, Jing H, Tang Y, Hu C, Song YW, Liu YP, Qi SN, Tang Y, Lu NN, Chen B, Zhai YR, Zhang WW, Li N, Fang H, Li YX, Wang SL. Wang DQ, et al. Among authors: zhai yr. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):186-197. doi: 10.1016/j.ijrobp.2023.03.060. Epub 2023 Mar 30. Int J Radiat Oncol Biol Phys. 2023. PMID: 37001764 Free article.
[The efficacy of radiotherapy based combined therapy for unresectable locally invasive bladder cancer and its associated factors analysis].
Zhong SJ, Gao JJ, Tang P, Liu YP, Wang SL, Fang H, Qiu JP, Song YW, Chen B, Qi SN, Tang Y, Lu NN, Jing H, Zhai YR, Zhou AP, Bi XG, Ma JH, Li CL, Zhang Y, Shou JZ, Xing NZ, Li YX. Zhong SJ, et al. Among authors: zhai yr. Zhonghua Zhong Liu Za Zhi. 2023 Feb 23;45(2):175-181. doi: 10.3760/cma.j.cn112152-20220714-00490. Zhonghua Zhong Liu Za Zhi. 2023. PMID: 36781240 Chinese.
Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy.
Zhou YM, Liu X, Yang Y, Wang SL, Fang H, Song YW, Liu YP, Jin J, Li N, Lu NN, Jing H, Tang Y, Chen B, Zhang WW, Zhai YR, Men K, Dai JR, Deng M, Qi SN, Li YX. Zhou YM, et al. Among authors: zhai yr. J Cancer Res Clin Oncol. 2023 Jul;149(8):5219-5230. doi: 10.1007/s00432-022-04472-6. Epub 2022 Nov 14. J Cancer Res Clin Oncol. 2023. PMID: 36374333
Individualized Clinical Target Volume for Irradiation of the Supraclavicular Region in Breast Cancer Based on Mapping of the Involved Ipsilateral Supraclavicular Lymph Nodes.
Jing H, Tang Y, Wang ZZ, Wei R, Jin JY, Li J, Zhao LY, Jin J, Liu YP, Song YW, Fang H, Chen B, Qi SN, Lu NN, Tang Y, Li N, Zhai YR, Zhang WW, Wang SL, Li YX. Jing H, et al. Among authors: zhai yr. Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):922-932. doi: 10.1016/j.ijrobp.2022.10.030. Epub 2022 Nov 9. Int J Radiat Oncol Biol Phys. 2023. PMID: 36368434
[Analysis of the efficacy and prognostic factors of 1 637 esophageal cancer patients treated with intensity-modulated radiotherapy].
Li C, Tan LJ, Liu X, Han WM, Gao LR, Wang SJ, Zhou ZM, Feng QF, Chen DF, Liang J, Lyu JM, Wang WQ, Hui ZG, Wang LH, Wang X, Liu WY, Deng L, Wang JY, Zhai YR, Zhang T, Bi N, Xiao ZF. Li C, et al. Among authors: zhai yr. Zhonghua Zhong Liu Za Zhi. 2021 Jun 23;43(6):678-684. doi: 10.3760/cma.j.cn112152-20201031-00952. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34289560 Chinese.
22 results